The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Plasmalogens participate in very-long-chain fatty acid-induced pathology
Abstract
Peroxisomes are organelles responsible for multiple metabolic pathways including, the biosynthesis of plasmalogens, a class of phospholipids, and the beta-oxidation of very-long-chain fatty acids (VLCFA). Lack of peroxisomes or dysfunction in any of their normal functions is the cellular basis for human peroxisomal disorders. Here we used mouse models to understand and define the biochemical and cellular determinants that mediate the pathophysiological consequences caused by peroxisomal dysfunctions. We investigated the role and effects of cellular plasmalogens and VLCFA accumulation in liver, testis and nervous tissue using Pex7 and Abcd1 knockout (KO) mice. In addition, we also generated a Pex7:Abcd1 double KO mouse to investigate how different peroxisomal dysfunctions modulate cellular function and pathology. We found that plasmalogens function as fundamental structural phospholipids and protect cells from damage caused by VLCFA accumulation. In testis, plasmalogens protect spermatocytes from VLCFA-induced degeneration and apoptosis. In nervous tissue, we found that gliosis, inflammatory demyelination and axonopathy caused by accumulation of VLCFA are modulated by plasmalogens. Our findings demonstrate the importance of normal peroxisomal functioning and allow the understanding of the pathological causality of peroxisomal dysfunctions. Nervous tissue deficient in plasmalogens is more prone to damage, illustrating the importance of plasmalogens in peroxisomal disorders including Zellweger syndrome and X-linked adrenoleukodystrophy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“VLCFA accumulation might also cause demyelination by limiting peroxisomal synthesis of plasmalogens [261,262], notably plasmenyl-ethanolamine [261].”
From Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy (2025) · cites this paper as [262]
Citations
Cites
Cahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129
Biochemistry of mammalian peroxisomes revisited
Wanders, R. J. A., & Waterham, H. R. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133329 · Cited by 995
Self-citationMoser, H. W., Mahmood, A., & Raymond, G. V. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0421 · Cited by 663
Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy
Moser, H. (1997) · Brain · doi:10.1093/brain/120.8.1485 · Cited by 478
Functions and biosynthesis of plasmalogens in health and disease
Brites, P., Waterham, H. R., & Wanders, R. J. A. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2003.12.010 · Cited by 430
Self-citationAxonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes
Kassmann, C. M., Lappe-Siefke, C., Baes, M., Brügger, B., Mildner, A., Werner, H. B., Natt, O., Michaelis, T., Prinz, M., Frahm, J., et al. (2007) · Nature Genetics · doi:10.1038/ng2070 · Cited by 357
A mouse model for X-linked adrenoleukodystrophy
Lu, J.-F., Lawler, A. M., Watkins, P. A., Powers, J. M., Moser, A. B., Moser, H. W., & Smith, K. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9366 · Cited by 293
A mouse model for Zellweger syndrome
Baes, M., Gressens, P., Baumgart, E., Carmeliet, P., Casteels, M., Fransen, M., Evrard, P., Fahimi, D., Declercq, P. E., Collen, D., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-49 · Cited by 275
POWERS, J. M., LIU, Y., MOSER, A. B., & MOSER, H. W. (1992) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199211000-00007 · Cited by 265
Goodenowe, D. B., Cook, L. L., Liu, J., Lu, Y., Jayasinghe, D., Ahiahonu, P. W. K., Heath, D., Yamazaki, Y., Flax, J., Krenitsky, K. F., et al. (2007) · Journal of Lipid Research · doi:10.1194/jlr.p700023-jlr200 · Cited by 259
Adrenoleukodystrophy: Survey of 303 cases: Biochemistry, diagnosis, and therapy
Moser, H. W., Moser, A. E., Singh, I., & OʼNeill, P. (1984) · Annals of Neurology · doi:10.1002/ana.410160603 · Cited by 258
Guan, Z., Wang, Y., Cairns, N. J., Lantos, P. L., Dallner, G., & Sindelar, P. J. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199907000-00008 · Cited by 236
Rodemer, C., Thai, T.-P., Brügger, B., Kaercher, T., Werner, H. B., Nave, K., Wieland, F., Gorgas, K., & Just, W. W. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg191 · Cited by 234
Pujol, A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.5.499 · Cited by 214
Peroxisome Biogenesis Disorders
Grønborg, S. W., Gould, S. J., & Valle, D. L. (2003) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.4.070802.110424 · Cited by 204
Adrenomyeloneuropathy: A Neuropathologic Review Featuring Its Noninflammatory Myelopathy
Powers, J. M., DeCiero, D. P., Ito, M., Moser, A. B., & Moser, H. W. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.2.89 · Cited by 204
X-linked adrenoleukodystrophy: Clinical, biochemical and pathogenetic aspects
Berger, J., & Gärtner, J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.07.010 · Cited by 199
Kobayashi, T., Shinnoh, N., Kondo, A., & Yamada, T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6340 · Cited by 197
X-linked adrenoleukodystrophy: Genes, mutations, and phenotypes
Smith, K. D., Kemp, S., Braiterman, L. T., Lu, J.-F., Wei, H.-M., Geraghty, M., Stetten, G., Bergin, J. S., Pevsner, J., & Watkins, P. A. (1999) · Neurochemical Research · doi:10.1023/a:1022535930009 · Cited by 190
Seedorf, U., Brysch, P., Engel, T., Schrage, K., & Assmann, G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31960-9 · Cited by 170
Human ATP-binding cassette (ABC) transporters and lipoprotein metabolism.
Stefkova, J., Poledne, R., & Hubacek, J. A. (2004) · Physiological Research · doi:10.33549/physiolres.930432 · Cited by 167
ATP-binding cassette (ABC) transporters in human metabolism and diseases.
Stefkova, J., Poledne, R., & Hubacek, J. A. (2004) · PubMed · Cited by 163
Role of ALDP (ABCD1) and Mitochondria in X-Linked Adrenoleukodystrophy
McGuinness, M. C., Lu, J.-F., Zhang, H.-P., Dong, G.-X., Heinzer, A. K., Watkins, P. A., Powers, J., & Smith, K. D. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.744-753.2003 · Cited by 147
Adreno-leukodystrophy: Oxidative Stress of Mice and Men
Powers, J. M., Pei, Z., Heinzer, A. K., Brose, R. D., Moser, A. B., Moser, H. W., Watkins, P. A., & Smith, K. D. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000190064.28559.a4 · Cited by 129
Brites, P. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg236 · Cited by 116
Self-citationThe peroxisomal ABC transporter family
Wanders, R. J. A., Visser, W. F., van Roermund, C. W. T., Kemp, S., & Waterham, H. R. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0142-x · Cited by 111
Self-citationVreken, P., van Lint, A. E. M., Bootsma, A. H., Overmars, H., Wanders, R. J. A., & Gennip, A. H. (1998) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(98)00186-8 · Cited by 99
Self-citationMeasurement of peroxisomal fatty acid β‐oxidation in cultured human skin fibroblasts
Wanders, R. J. A., Denis, S. W., Ruiter, J. P. N., Schutgens, R. B. H., van Roermund, C. W. T., & Jacobs, B. S. (1995) · Journal of Inherited Metabolic Disease · doi:10.1007/bf00711434 · Cited by 95
Self-citationPlasma and Red Blood Cell Fatty Acids in Peroxisomal Disorders
Moser, A. B., Jones, D. S., Raymond, G. V., & Moser, H. W. (1999) · Neurochemical Research · doi:10.1023/a:1022549618333 · Cited by 92
Wanders, R. J. A., Denis, S. W., Wouters, F. S., WIRTZ, K. W. A., & Seedorf, U. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7007 · Cited by 90
Self-citationMembrane Instability, Plasmalogen Content, and Alzheimer's Disease
Ginsberg, L., Xuereb, J. H., & Gershfeld, N. L. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70062533.x · Cited by 89
Plasmalogen deficiency in cerebral adrenoleukodystrophy and its modulation by lovastatin
Khan, M., Singh, J., & Singh, I. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05513.x · Cited by 84
Faust, P. L., Banka, D., Siriratsivawong, R., Ng, V. G., & Wikander, T. M. (2005) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-005-7059-y · Cited by 82
The pathology of peroxisomal disorders with pathogenetic considerations.
Powers, J. M. (1995) · PubMed · Cited by 72
Assay of plasmalogens and polyunsaturated fatty acids (PUFA) in erythrocytes and fibroblasts
Dacremont, G., & Vincent, G. (1995) · Journal of Inherited Metabolic Disease · doi:10.1007/bf00711431 · Cited by 71
Lipid and fatty acid composition of brain tissue from adrenoleukodystrophy patients
Wilson, R., & Sargent, J. R. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03567.x · Cited by 67
PRESIDENTIAL ADDRESS: The Pathology of Peroxisomal Disorders with Pathogenetic Considerations
Powers, J. M. (1995) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199509000-00014 · Cited by 67
Purdue, P. E., Skoneczny, M., Yang, X., Zhang, J.-W., & Lazarow, P. B. (1999) · Neurochemical Research · doi:10.1023/a:1023957110171 · Cited by 49
Prenatal and postnatal development of peroxisomal lipid-metabolizing pathways in the mouse
Huyghe, S., Casteels, M., Janssen, A., MEULDERS, L., Mannaerts, G. P., Declercq, P. E., Veldhoven, P. P. V., & Baes, M. I. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3530673 · Cited by 48
Baes, M. I., Gressèns, P., Huyghe, S., Nys, K. D., Qi, C., Jia, Y., Mannaerts, G. P., Evrard, P., Veldhoven, P. P. V., Declercq, P. E., et al. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.4.368 · Cited by 47
Quantitative proteomic comparison of mouse peroxisomes from liver and kidney
Mi, J., Kirchner, E., & Cristobal, S. (2007) · PROTEOMICS · doi:10.1002/pmic.200600638 · Cited by 46
Plasmalogen levels in Gaucher disease.
Moraitou, M., Dimitriou, E., Zafeiriou, D., Reppa, C., Marinakis, T., Sarafidou, J., & Michelakakis, H. (2008) · Blood Cells, Molecules & Diseases · doi:10.1016/j.bcmd.2008.03.007 · Cited by 32
Lessons from Knockout Mice. I: Phenotypes of Mice with Peroxisome Biogenesis Disorders
Baes, M. I., & Veldhoven, P. P. V. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9072-3_16 · Cited by 9
The mouse as a model to understand peroxisomal biogenesis and its disorders
Brites, P., Wanders, R. J. A., & Waterham, H. R. (2004) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2004.09.003 · Cited by 6
Self-citationForss-Petter, S. (1997) · doi:10.1002/(sici)1097-4547(19971201)50:5
Cited by
Sorted by citations
Functions of plasmalogen lipids in health and disease
Braverman, N. E., & Moser, A. B. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.05.008 · Cited by 1,082
Peroxisomes: A Nexus for Lipid Metabolism and Cellular Signaling
Lodhi, I. J., & Semenkovich, C. F. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.002 · Cited by 605
Myelin Fat Facts: An Overview of Lipids and Fatty Acid Metabolism
Poitelon, Y., Kopec, A. M., & Belin, S. (2020) · Cells · doi:10.3390/cells9040812 · Cited by 394
Myelin Proteomics: Molecular Anatomy of an Insulating Sheath
Jahn, O., Tenzer, S., & Werner, H. B. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8071-2 · Cited by 355
Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models
Chrast, R., Saher, G., Nave, K.-A., & Verheijen, M. H. G. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r009761 · Cited by 314
Metadata
- Authors
- Brites, P., Mooyer, P. A. W., el Mrabet, L., Waterham, H. R., & Wanders, R. J. A.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-06-20
- Volume
- 132
- Issue
- 2
- Pages
- 482-492
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2060819989
- Cited by
- 112
- References
- 45
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 2 · 2023: 3 · 2022: 6 · 2021: 1 · 2020: 6 · 2019: 8 · 2018: 4 · 2017: 4 · 2016: 5 · 2015: 5 · 2014: 11 · 2013: 5 · 2012: 9
- FWCI
- 7.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Funders
- European Commission
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Keywords
- plasmalogens, very long chain fatty acids, peroxisomal disorders, peroxisomes, PEX7, ABCD1, spermatocyte degeneration, apoptosis, gliosis, inflammatory demyelination, axonopathy, Zellweger syndrome, X-linked adrenoleukodystrophy, fatty acid accumulation, phospholipids
- MeSH terms
- Peroxisomal Targeting Signal 2 Receptor, Adrenoleukodystrophy, Animals, Astrocytes, Axons, Brain, Demyelinating Diseases, Fatty Acids, Male, Mice, Inbred C57BL, Plasmalogens, Blotting, Western, Microglia, Receptors, Cytoplasmic and Nuclear, Mice, Knockout, Peroxisomes, Mice, Chemokine CCL22
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
